La « non-progression » de l'infection à VIH : une origine multi-factorielle ? = non-progression in HIV infection: a multifactorial process ?MORAND-JOUBERT, L.Virologie (Montrouge). 2001, Vol 5, Num 2, pp 113-119, issn 1267-8694Article

Mise au point concernant la résistance au saquinavir = Resistance to saquinavir: state of the artMORAND-JOUBERT, L.La Lettre du pharmacologue (Boulogne). 2002, Vol 16, Num 3, pp 93-97, issn 0984-452XArticle

Tropismes et sous-types virauxMORAND-JOUBERT, L.TRANSCRIPTASE. 2008, Num 139, pp 11-12, issn 1166-5300, 2 p.Article

Nouvelle surveillance biologique de l'infection par le VIH = Present biological monitoring of HIV infectionMORAND-JOUBERT, L.La Revue du praticien (Paris). 1998, Vol 48, Num 5, pp 472-477, issn 0035-2640Article

Quantification génomique du virus HTLV-I = Genomic quantization of HTLV-I virusLEFRERE, J.-J; MORAND-JOUBERT, L.Virologie (Montrouge). 1997, Vol 1, Num NOV, pp 62-67, issn 1267-8694, NSArticle

Quantification objective des anticorps sériques anti-VIH1 et anti-HTLV-I = Quantitation of serum anti-HIV1 or anti-HTLV-I antibodyLEFRERE, J.-J; MORAND-JOUBERT, L.Virologie (Montrouge). 1997, Vol 1, Num 5, pp 423-424, issn 1267-8694Article

Transmission et persistance de virus de l'immunodéficence humaine multirésistants pendant 2 ans sans traitement antirétroviral = Transmission and persistence of multiresistant human immunodeficiency viruses in the absence of any antiretroviral therapy over two yearsDELAUGERRE, C; MORAND-JOUBERT, L; CHAIX, M.-L et al.Virologie (Montrouge). 2004, Vol 8, Num 3, pp 235-236, issn 1267-8694, 2 p.Article

Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigenMORAND-JOUBERT, L; BLUDAU, H; LERABLE, J et al.Journal of medical virology. 1995, Vol 47, Num 1, pp 87-91, issn 0146-6615Article

Plasma human immunodeficiency virus RNA below 40 copies/mL is rare in untreated persons even in the first years of infectionLEFRERE, J.-J; MARIOTTI, M; MORAND-JOUBERT, L et al.The Journal of infectious diseases. 1999, Vol 180, Num 2, pp 526-529, issn 0022-1899Article

Predicting progression of HIV disease : usefulness of acid-dissociated p24 antigenMORAND-JOUBERT, L; COSTAGLIOLA, D; BLUDAU, H et al.Journal of acquired immune deficiency syndromes. 1994, Vol 7, Num 7, pp 676-680, issn 0894-9255Article

Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected personsLEFRERE, J.-J; ROUDOT-THORAVAL, F; MORAND-JOUBERT, L et al.The Journal of infectious diseases. 1999, Vol 179, Num 4, pp 783-789, issn 0022-1899Article

Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretionsBELEC, L; GEORGES, A. J; HALLOUIN, M.-C et al.AIDS research and human retroviruses. 1996, Vol 12, Num 2, pp 157-167, issn 0889-2229Article

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 studyVALANTINL, M. A; LAMBERT-NICLOT, S; CUZIN, L et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 3, pp 691-695, issn 0305-7453, 5 p.Article

Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infectionLEFRERE, J.-J; MORAND-JOUBERT, L; MARIOTTI, M et al.Blood. 1997, Vol 90, Num 3, pp 1133-1140, issn 0006-4971Article

Virological and immunological data of AIDS patients treated by passive immunotherapy (transfusions of plasma rich in HIV-1 antibodies)MORAND-JOUBERT, L; VITTECOQ, D; ROUDOT-THORAVAL, F et al.Vox sanguinis (Basel. 1956). 1997, Vol 73, Num 3, pp 149-154, issn 0042-9007Article

Facteurs prédictifs de réponse virologique à un traitement antirétroviral avec inhibiteur de protéase au cours de l'infection à VIH = Factors predicting response to antiretroviral regimens with a protease inhibitor in HIV-infected subjectsMEYNARD, J. L; GUIGUET, M; RACHLINE, A et al.La Presse médicale (1983). 2001, Vol 30, Num 1, pp 5-10, issn 0755-4982Article

Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses : evidence of sexual and parenteral transmissionLEFRERE, J. J; ROUDOT-THORAVAL, F; GIROT, R et al.Transfusion (Philadelphia, PA). 1999, Vol 39, Num 1, pp 83-94, issn 0041-1132Article

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection : Results of a case-control studySERFATY, L; CHAZOUILLERES, O; POUJOL-ROBERT, A et al.Hepatology (Baltimore, Md.). 1997, Vol 26, Num 3, pp 776-779, issn 0270-9139Article

Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodiesLEFRERE, J. J; ROUDOT-THORAVAL, F; VITTECOQ, D et al.Transfusion (Philadelphia, PA). 1996, Vol 36, Num 8, pp 734-738, issn 0041-1132Article

Tests rapides d'orientation et de diagnostic de l'infection par le VIH en CDAG : expérience pilote en France (janvier 2010-janvier 2011)PICARD, O; GIRARD, P.M; MORAND JOUBERT, L et al.Bulletin épidémiologique hebdomadaire. 2011, Num 42, pp 438-441, issn 0245-7466, 4 p.Article